Robert A.B. van Waterschoot

1.4k citations
20 papers · 1.2k indexed · h-index 16
Topics
Drug Transport and Resistance Mechanisms (17 papers)Pharmacogenetics and Drug Metabolism (13 papers)Pharmacological Effects and Toxicity Studies (8 papers)

In The Last Decade

Robert A.B. van Waterschoot

20 papers receiving 1.1k citations

Peers

Robert A.B. van Waterschoot
Comparison fields: 5 of 93
  • Oncology 725
  • Pharmacology 419
  • Molecular Biology 332
  • Pediatrics, Perinatology and Child Health 233
  • Genetics 83
Replace Cindy Q. Xia with:
Cindy Q. Xia United States
Cornelia M.M. van der Kruijssen Netherlands
Manfred G. Ismair Switzerland
Nicola F. Smith United States
Kathleen Köck United States
A Moreau France
Pauline Breedveld Netherlands
Mayumi Saeki Japan
Yannick Parmentier France
Camille Granvil United States
Robert A.B. van Waterschoot relative to Cindy Q. Xia United States Cindy Q. Xia's profile →
Citations per field
00.5×1.5×
Cindy Q. Xia · 1×
Citations per year

Countries citing papers authored by Robert A.B. van Waterschoot

Since Specialization
Citations

This map shows the geographic impact of Robert A.B. van Waterschoot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert A.B. van Waterschoot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert A.B. van Waterschoot more than expected).

Fields of papers citing papers by Robert A.B. van Waterschoot

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert A.B. van Waterschoot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert A.B. van Waterschoot. The network helps show where Robert A.B. van Waterschoot may publish in the future.

Co-authorship network of co-authors of Robert A.B. van Waterschoot

This figure shows the co-authorship network connecting the top 25 collaborators of Robert A.B. van Waterschoot. A scholar is included among the top collaborators of Robert A.B. van Waterschoot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert A.B. van Waterschoot. Robert A.B. van Waterschoot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 19
2 20
3 30
4 25
5 4
6 97
7 151
8 15
9 44
10 13
11 85
12 43
13 54
14 140
15 29
16 52
17 41
18 97
19 189
20 6

About Robert A.B. van Waterschoot

Robert A.B. van Waterschoot is a scholar working on Pharmacology, Oncology and Pediatrics, Perinatology and Child Health, having authored 20 papers that have together received 1.2k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (17 papers), Pharmacogenetics and Drug Metabolism (13 papers) and Pharmacological Effects and Toxicity Studies (8 papers). The work is most often cited by research in Pharmacology (419 citations), Oncology (725 citations) and Pediatrics, Perinatology and Child Health (233 citations). Robert A.B. van Waterschoot has collaborated with scholars based in Netherlands, Switzerland and United States. Frequent co-authors include Alfred H. Schinkel, Jos H. Beijnen, Els Wagenaar, Jurjen S. Lagas, Antonius E. van Herwaarden, Rolf W. Sparidans, Hilde Rosing, Cornelia M.M. van der Kruijssen, Rogier W. Rooswinkel and Olaf van Tellingen. Their work appears in journals such as Journal of Clinical Investigation, Nature Reviews Drug Discovery and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026